Dopaminergic involvement in medial prefrontal cortex and core of the nucleus accumbens in the regulation of ethanol self-administration: a dual-site microinjection study in the rat.
The complex mesolimbic-mesocortical system involved with behavioral selection has been implicated in the control of ethanol self-administration. However, the nature of the interactions within this multiple-structured system in ethanol intake regulation remains unclear. Although the role of dopamine (DA) in the prefrontal cortex and the nucleus accumbens has been examined individually, the interaction of DA activity in both structures at the same time remains to be examined. Male, Long-Evans rats were initiated to self-administer ethanol in an operant situation using the sucrose-substitution procedure. Following initiation, bilateral cannula guides were located to allow microinjection in the medial prefrontal cortex (mPFC) and the core of the nucleus accumbens. The DA D2/D3 agonist quinpirole (10.0-microg dose in the prefrontal cortex; 4.0-microg dose in n. accumbens) and the D2 antagonist raclopride (0.05-microg dose in prefrontal cortex; 1.0-microg dose in the nucleus accumbens) were then tested in each site alone and in combination in both sites in each rat. Changes in total responding, ethanol intake, and the pattern of responding were analyzed. Single-site injections replicated most of our previous findings for these doses. Changes in single-site effects were found when dual-site injections were performed, with altered input from the prefrontal areas impacting the effects of accumbens injections. Based on these interactions, our hypothesis that the prefrontal area is involved with the onset and offset of drinking, while the nucleus accumbens is involved with maintaining the ongoing behavior, remains viable.
Samson
Herman H
HH
Center for the Neurobehavioral Study of Alcohol, Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1083, USA. hsamson@wfubmc.edu
Chappell
Ann
A
D000428:Alcohol Drinking / Q000378:metabolism*; D000818:Animals; D001066:Appetite / Q000502:physiology; D003216:Conditioning, Operant; D004298:Dopamine / Q000378:metabolism*; D018491:Dopamine Agonists / Q000008:administration & dosage; D018492:Dopamine Antagonists / Q000008:administration & dosage; D000431:Ethanol / Q000008:administration & dosage*; D008297:Male; D008845:Microinjections; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism*; D019257:Quinpirole / Q000008:administration & dosage; D020891:Raclopride / Q000008:administration & dosage; D051381:Rats; D020318:Rats, Long-Evans; D012646:Self Administration
D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D019257:Quinpirole; D000431:Ethanol; D020891:Raclopride; D004298:Dopamine